These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20132932)

  • 1. Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone.
    Feng C; Meldrum S; Fiscella K
    Int J Gynaecol Obstet; 2010 May; 109(2):121-4. PubMed ID: 20132932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.
    Fiscella K; Eisinger SH; Meldrum S; Feng C; Fisher SG; Guzick DS
    Obstet Gynecol; 2006 Dec; 108(6):1381-7. PubMed ID: 17138770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.
    Eisinger SH; Fiscella J; Bonfiglio T; Meldrum S; Fiscella K
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):215-8. PubMed ID: 19586708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
    Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herbal preparations for uterine fibroids.
    Liu JP; Yang H; Xia Y; Cardini F
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005292. PubMed ID: 23633329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.
    Liu C; Lu Q; Qu H; Geng L; Bian M; Huang M; Wang H; Zhang Y; Wen Z; Zheng S; Zhang Z
    Medicine (Baltimore); 2017 Feb; 96(7):e6124. PubMed ID: 28207540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.
    Yerushalmi GM; Gilboa Y; Jakobson-Setton A; Tadir Y; Goldchmit C; Katz D; Seidman DS
    Fertil Steril; 2014 Feb; 101(2):496-500. PubMed ID: 24220703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of uterine leiomyoma by two different doses of mifepristone].
    Yang Y; Zheng S; Li K
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):624-6. PubMed ID: 9275461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of uterine myoma with 5 or 10mg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trial.
    Esteve JL; Acosta R; Pérez Y; Campos R; Hernández AV; Texidó CS
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):202-8. PubMed ID: 22269473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of mifepristone for the treatment of uterine leiomyomata.
    Steinauer J; Pritts EA; Jackson R; Jacoby AF
    Obstet Gynecol; 2004 Jun; 103(6):1331-6. PubMed ID: 15172874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network meta-analysis of 6 kinds of Chinese patent medicines combined with mifepristone in the treatment of uterine fibroids: A protocol for systematic review and network meta-analysis.
    Bi C; Qiao M; Jia Y; Wang H
    Medicine (Baltimore); 2021 Oct; 100(42):e27523. PubMed ID: 34678886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone for the treatment of uterine leiomyomas: methodological issues and clinical implications.
    Erenbourg A; Piccoli M; Ronfani L; Tamburlini G
    Obstet Gynecol; 2009 Mar; 113(3):741. PubMed ID: 19300345
    [No Abstract]   [Full Text] [Related]  

  • 15. [A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].
    Zeng C; Gu M; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):490-2. PubMed ID: 10806751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial.
    Fiscella K; Eisinger S
    Obstet Gynecol; 2008 Sep; 112(3):707; author reply 707-8. PubMed ID: 18757682
    [No Abstract]   [Full Text] [Related]  

  • 17. Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial.
    Carbonell Esteve JL; Acosta R; Heredia B; Pérez Y; Castañeda MC; Hernández AV
    Obstet Gynecol; 2008 Nov; 112(5):1029-36. PubMed ID: 18978102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preoperative treatment of uterine fibroids with low-dose mifepristone: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study].
    Bian ML; Huang ML; Zhang ZY; Liu SM; Sun J; Fang F; Gu YP; Liu CD; Yao C
    Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):317-327. PubMed ID: 34034418
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term use of ultra-low-dose mifepristone for uterine leiomyoma control and safety discussion: A case report.
    Zhou G; Li Q
    Medicine (Baltimore); 2022 Dec; 101(52):e32413. PubMed ID: 36595976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose mifepristone for uterine leiomyomata.
    Eisinger SH; Meldrum S; Fiscella K; le Roux HD; Guzick DS
    Obstet Gynecol; 2003 Feb; 101(2):243-50. PubMed ID: 12576246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.